Danielle Vanark RDH

Recommended Articles

• 5 Tips on Living with Kidney Stones

  According to scientific research, around 15% of the world’s population is living with kidney stones. Among these people, 20% are men while 5% are women. Kidney stones is a condition which is very common especially in men. It is also among the most painful infections since it affects the urinary...

• How To Help Your Loved One Combat Geriatric Depression

  Clinical depression is very common in elderly people. While the cause of depression is different depending on the individual, one of the main reasons behind geriatric depression is loneliness. Family members usually focus on the physical health of their elders and deliberately ignore another...

• You Might End Up Copying Your Friend's Eating Habits

  According to an interesting study published in, American Journal of Public Health, friends and family members may start sharing the eating patterns after some time. Some of the earlier studies had tried to find the spread of obesity in social networks. In the present study, the researchers wanted...

• Companies Want to Work with People Who Have Autism

  In the United States, statistics indicate that as many as 80-90% of adults on the autism spectrum are either unemployed or underemployed. These poor outcomes are not the result of an inability among individuals with autism to demonstrate their competence and to perform job tasks. Rather, for the...

• What Is Ulcerative Colitis?

  There are a few problems that can affect the digestive tract and cause problems, and they are generally referred to as irritable bowel diseases (IBD). The most common IBDs are Crohn’s disease and ulcerative colitis. IBD is different from IBS – Irritable Bowel Syndrome, which does not cause...

• New Treatment for Celiac Disease Using Nanoparticles Is Underway

  Recently, investigators have found a potential way to develop a treatment for celiac disease, which, according to Cour Pharmaceuticals focuses on the autoimmune disease, along with other inflammatory diseases. The treatment has been approved for clinical trials in August, 2017, and these trials have...